HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS:SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the appointment of Brian Holzer to the position of Executive Director of Brand Management. Dr. Holzer will report to Rick Gonzalez, Vice President of Business Solutions and Government Affairs. He will be primarily responsible for leading and managing Spectrum’s cross-functional brand efforts for FUSILEV® and ZEVALIN® as well as brand planning for apaziquone and belinostat, Spectrum’s late-stage drugs in development.
